Understanding 30 Gy Radiation Therapy for Stage I DLBCL
What 30 Gy Means
30 Gy (Gray) represents the total cumulative radiation dose you will receive, typically delivered in 10-15 separate treatment sessions (fractions) over 2-3 weeks. 1
Standard Fractionation Schedule
Most commonly, 30 Gy is delivered as 15 fractions of 2 Gy each, given once daily, 5 days per week (Monday through Friday), completing treatment in 3 weeks. 1
Alternatively, 30 Gy can be delivered as 10 fractions of 3 Gy each over 2 weeks, though the 15-fraction approach using 2 Gy per day is more standard for lymphoma. 1
Why This Dose for Stage I DLBCL
For early-stage diffuse large B-cell lymphoma treated with combined modality therapy (chemotherapy plus radiation), the recommended radiation dose is 30-36 Gy when combined with chemotherapy regimens like R-CHOP. 1
This dose range (30-36 Gy) provides excellent local control while minimizing long-term toxicity, which is particularly important for young, otherwise healthy patients who have decades of life expectancy ahead. 1
Treatment Delivery Details
Each treatment session (fraction) takes approximately 10-15 minutes, though you'll spend more time in positioning and setup. 1
The radiation is delivered using involved-site radiation therapy (ISRT), which targets only the originally involved lymph node areas identified on your pre-treatment PET/CT scan, sparing surrounding healthy organs. 1
Modern techniques like 3D conformal radiation or intensity-modulated radiation therapy (IMRT) are used to precisely shape the radiation beam to the tumor while protecting normal tissues. 1
Expected Timeline
If receiving 30 Gy in 15 fractions: Treatment occurs Monday-Friday for 3 consecutive weeks (total of 15 treatment days). 1
If receiving 30 Gy in 10 fractions: Treatment occurs Monday-Friday for 2 consecutive weeks (total of 10 treatment days). 1
Important Context for Your Situation
For stage I DLBCL, the standard approach combines abbreviated chemotherapy (typically 3-4 cycles of R-CHOP) followed by involved-site radiation therapy. 2
The 10-year overall survival for limited-stage DLBCL treated with combined modality therapy exceeds 70-80%, making this one of the most curable lymphomas. 2
The radiation component is critical for maximizing local control and preventing relapse in the originally involved areas. 2